Larson Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $361K | Sell |
811
-25
| -3% | -$11.1K | 0.01% | 522 |
|
|
2025
Q1 | $405K | Buy |
836
+350
| +72% | +$170K | 0.02% | 449 |
|
|
2024
Q4 | $196K | Buy |
486
+69
| +17% | +$27.8K | 0.01% | 564 |
|
|
2024
Q3 | $194K | Buy |
417
+75
| +22% | +$34.9K | 0.01% | 579 |
|
|
2024
Q2 | $160K | Buy |
342
+114
| +50% | +$53.4K | 0.01% | 529 |
|
|
2024
Q1 | $95.3K | Buy |
228
+200
| +714% | +$83.6K | 0.01% | 552 |
|
|
2023
Q4 | $11.4K | Sell |
28
-78
| -74% | -$31.7K | ﹤0.01% | 979 |
|
|
2023
Q3 | $36.9K | Buy |
106
+51
| +93% | +$17.7K | ﹤0.01% | 689 |
|
|
2023
Q2 | $19.4K | Buy |
55
+30
| +120% | +$10.6K | ﹤0.01% | 744 |
|
|
2023
Q1 | $7.88K | Hold |
25
| – | – | ﹤0.01% | 989 |
|
|
2022
Q4 | $7.22K | Hold |
25
| – | – | ﹤0.01% | 953 |
|
|
2022
Q3 | $7K | Hold |
25
| – | – | ﹤0.01% | 894 |
|
|
2022
Q2 | $7K | Hold |
25
| – | – | ﹤0.01% | 808 |
|
|
2022
Q1 | $7K | Hold |
25
| – | – | ﹤0.01% | 746 |
|
|
2021
Q4 | $5K | Buy |
+25
| New | +$5K | ﹤0.01% | 828 |
|
|
2019
Q3 | – | Sell |
-25
| Closed | -$5K | – | 630 |
|
|
2019
Q2 | $5K | Buy |
+25
| New | +$5K | ﹤0.01% | 322 |
|